These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20481503)
21. A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery. Wang XL; Jensen R; Lu ZR J Control Release; 2007 Jul; 120(3):250-8. PubMed ID: 17582638 [TBL] [Abstract][Full Text] [Related]
22. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related]
23. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine. Shim MS; Kwon YJ Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606 [TBL] [Abstract][Full Text] [Related]
24. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537 [TBL] [Abstract][Full Text] [Related]
25. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. Jere D; Jiang HL; Kim YK; Arote R; Choi YJ; Yun CH; Cho MH; Cho CS Int J Pharm; 2009 Aug; 378(1-2):194-200. PubMed ID: 19501140 [TBL] [Abstract][Full Text] [Related]
26. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969 [TBL] [Abstract][Full Text] [Related]
27. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674 [TBL] [Abstract][Full Text] [Related]
28. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
29. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles. Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769 [TBL] [Abstract][Full Text] [Related]
30. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. Buyens K; Meyer M; Wagner E; Demeester J; De Smedt SC; Sanders NN J Control Release; 2010 Jan; 141(1):38-41. PubMed ID: 19737587 [TBL] [Abstract][Full Text] [Related]
31. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. Kim SH; Jeong JH; Lee SH; Kim SW; Park TG J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481 [TBL] [Abstract][Full Text] [Related]
32. Degradable polyethylenimines as DNA and small interfering RNA carriers. Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333 [TBL] [Abstract][Full Text] [Related]
33. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Jiang G; Park K; Kim J; Kim KS; Hahn SK Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932 [TBL] [Abstract][Full Text] [Related]
35. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409 [TBL] [Abstract][Full Text] [Related]
37. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Kwon EJ; Bergen JM; Pun SH Bioconjug Chem; 2008 Apr; 19(4):920-7. PubMed ID: 18376855 [TBL] [Abstract][Full Text] [Related]
38. Oligobenzylethylenimine enriches linear polyethylenimine with a pH-sensitive membrane-disruptive property and leads to enhanced gene delivery activity. Chandrashekhar C; Pons B; Muller CD; Tounsi N; Mulherkar R; Zuber G Acta Biomater; 2013 Feb; 9(2):4985-93. PubMed ID: 23000009 [TBL] [Abstract][Full Text] [Related]
39. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
40. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier. Kang JH; Tachibana Y; Kamata W; Mahara A; Harada-Shiba M; Yamaoka T Bioorg Med Chem; 2010 Jun; 18(11):3946-50. PubMed ID: 20472444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]